Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model. [PDF]
BMC Cardiovasc Disord, 2021 Sullivan RT +6 more
europepmc +1 more source
247. Expressing Full-Length Dystrophin in 50% Cardiomyocytes Corrects Cardiomyopathy in the Mdx Mouse Model for Duchenne Muscular Dystrophy [PDF]
, 2004 Zhilong Jiang, Paula R. Clemens
openalex +1 more source
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model [PDF]
, 2006 Michela A. Denti +12 more
openalex +1 more source
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy. [PDF]
Int J Mol Sci, 2022 Bourg N +11 more
europepmc +1 more source
Morpholino Oligomer–Mediated Exon Skipping Averts the Onset of Dystrophic Pathology in the mdx Mouse [PDF]
, 2007 Sue Fletcher +8 more
openalex +1 more source
347. The Use of CpG Modifications Enhances Gene Correction Levels Mediated by Oligonucleotides in the Mdx Mouse Model for Duchenne Muscular Dystrophy [PDF]
, 2008 openalex +1 more source
Cell surface and gene expression regulation molecules in dystrophinopathy: mdx vs. Duchenne
Biological Research, 2005 Duchenne muscular dystrophy (DMD) is secondary to loss-of-function mutations in the dystrophin gene. The causes underlying the progression of DMD, differential muscle involvement, and the discrepancies in phenotypes among species with the same genetic ...
RICARDO FADIC
doaj
Growth hormone secretagogues modulate inflammation and fibrosis in <i>mdx</i> mouse model of Duchenne muscular dystrophy. [PDF]
Front Immunol, 2023 Boccanegra B +20 more
europepmc +1 more source